BCL2 and gastric adenocarcinoma: Another work showed that the antineoplastic drug 5-FU decreased the mRNA levels of Bcl-2 in the first 48 h, which coincided with the up-regulation of BAX, after 72 h of treatment Bcl-2 was up-regulated and the levels of BAX were decreased in human gastric adenocarcinoma [64].